Evotec Historical Financial Ratios
| EVO Stock | USD 4.18 0.18 4.13% |
Evotec SE is recently reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 2.21 or Days Sales Outstanding of 62.97 will help investors to properly organize and evaluate Evotec SE ADR financial condition quickly.
Evotec |
About Evotec Financial Ratios Analysis
Evotec SE ADRFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Evotec SE investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Evotec financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Evotec SE history.
Evotec SE Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Evotec SE ADR stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Evotec SE sales, a figure that is much harder to manipulate than other Evotec SE ADR multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Evotec SE ADR dividend as a percentage of Evotec SE stock price. Evotec SE ADR dividend yield is a measure of Evotec SE stock productivity, which can be interpreted as interest rate earned on an Evotec SE investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Evotec SE's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Evotec SE ADR current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At this time, Evotec SE's Payables Turnover is very stable compared to the past year. As of the 13th of January 2025, Sales General And Administrative To Revenue is likely to grow to 0.26, while Dividend Yield is likely to drop 0.
| 2024 | 2025 (projected) | Dividend Yield | 0.001154 | 0.001096 | Price To Sales Ratio | 5.54 | 6.99 |
Evotec SE fundamentals Correlations
Click cells to compare fundamentals
Evotec SE Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evotec SE fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 9.29 | 11.44 | 3.59 | 4.82 | 5.54 | 6.99 | |
| Ptb Ratio | 6.44 | 5.13 | 2.27 | 3.36 | 3.03 | 2.21 | |
| Days Sales Outstanding | 99.74 | 90.56 | 133.95 | 57.64 | 66.28 | 62.97 | |
| Book Value Per Share | 4.7 | 8.28 | 6.72 | 6.33 | 7.28 | 11.65 | |
| Free Cash Flow Yield | (0.0117) | 4.66E-4 | 0.008068 | (0.0477) | (0.0429) | (0.0451) | |
| Operating Cash Flow Per Share | 0.28 | 0.29 | 0.73 | 1.15 | 0.21 | 0.19 | |
| Stock Based Compensation To Revenue | 0.0106 | 0.0126 | 0.0132 | 0.0123 | 0.0142 | 0.0199 | |
| Capex To Depreciation | 1.77 | 1.76 | 2.22 | 2.32 | 2.09 | 2.2 | |
| Pb Ratio | 6.44 | 5.13 | 2.27 | 3.36 | 3.03 | 2.21 | |
| Ev To Sales | 9.43 | 11.14 | 3.71 | 4.97 | 4.47 | 4.88 | |
| Free Cash Flow Per Share | (0.35) | 0.0198 | 0.12 | (1.01) | (0.91) | (0.96) | |
| Roic | 0.011 | 0.0143 | 0.009397 | (0.0318) | (0.0286) | (0.03) | |
| Inventory Turnover | 27.62 | 18.09 | 19.36 | 19.63 | 17.67 | 15.42 | |
| Net Income Per Share | 0.0408 | 1.3 | (0.99) | (0.47) | (0.43) | (0.45) | |
| Days Of Inventory On Hand | 13.22 | 20.18 | 18.85 | 18.59 | 21.38 | 28.13 | |
| Payables Turnover | 8.82 | 6.43 | 5.94 | 4.51 | 4.06 | 4.96 | |
| Capex To Revenue | 0.2 | 0.19 | 0.24 | 0.28 | 0.25 | 0.26 | |
| Cash Per Share | 3.2 | 5.16 | 4.13 | 3.41 | 3.93 | 3.75 | |
| Pocfratio | 104.1 | 57.86 | 13.27 | 103.32 | 92.99 | 97.64 | |
| Interest Coverage | 5.73 | 2.95 | 0.95 | (4.05) | (3.64) | (3.82) | |
| Capex To Operating Cash Flow | 2.22 | 0.97 | 0.89 | 5.93 | 5.33 | 5.6 | |
| Pfcf Ratio | (85.66) | 2.1K | 123.94 | (20.97) | (18.87) | (17.93) | |
| Days Payables Outstanding | 41.39 | 56.8 | 61.49 | 80.85 | 92.98 | 78.5 | |
| Income Quality | 7.15 | 0.57 | (1.16) | (0.43) | (0.39) | (0.37) | |
| Roe | 0.008685 | 0.16 | (0.15) | (0.0749) | (0.0674) | (0.0708) | |
| Ev To Operating Cash Flow | 105.66 | 56.33 | 13.72 | 106.48 | 95.83 | 100.62 | |
| Pe Ratio | 741.58 | 32.82 | (15.35) | (44.87) | (40.38) | (38.36) | |
| Return On Tangible Assets | 0.005618 | 0.11 | (0.0897) | (0.0428) | (0.0385) | (0.0404) | |
| Ev To Free Cash Flow | (86.94) | 2.1K | 128.15 | (21.61) | (19.45) | (18.48) | |
| Earnings Yield | 0.001348 | 0.0305 | (0.0652) | (0.0223) | (0.0201) | (0.0211) | |
| Intangibles To Total Assets | 0.45 | 0.32 | 0.24 | 0.13 | 0.12 | 0.11 | |
| Net Debt To E B I T D A | 0.92 | (0.62) | (1.06) | 14.74 | 13.26 | 13.93 | |
| Current Ratio | 3.16 | 3.39 | 3.18 | 1.94 | 2.24 | 3.53 | |
| Tangible Book Value Per Share | 2.45 | 6.55 | 5.03 | 4.68 | 5.39 | 10.41 | |
| Receivables Turnover | 3.66 | 4.03 | 2.72 | 6.33 | 7.28 | 5.67 |
Pair Trading with Evotec SE
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evotec SE position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will appreciate offsetting losses from the drop in the long position's value.Moving together with Evotec Stock
Moving against Evotec Stock
| 0.91 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.88 | LLY | Eli Lilly | PairCorr |
| 0.88 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.72 | UPC | Universe Pharmaceuticals | PairCorr |
| 0.63 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE ADR to buy it.
The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evotec SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evotec SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evotec SE can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.50) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets | Return On Equity |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.